US40637HAJ86 · Corp · USD

Halozyme Therapeutics Inc 144a 0.88% 2032/11

Halozyme Therapeutics Inc 144aUnited StatesPRIV PLACEMENTSenior Unsecured
MID PRICE
98.99
par = 100
YIELD TO MAT.
1.10%
semi-annual
COUPON
0.880%
semi-annual · fixed
MATURITY
2032-11-15
bullet · 6.54y
OUTSTANDING
not disclosed
AS OF
2026-04-30
Fund disclosure

Sign up free to see prices on this bond

Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.

Risk analytics

SEMI-ANNUAL · BULLET · PAR 100
Modified duration
6.31 y
1bp ↑ ≈ -0.063% P&L
Convexity
43.74
higher = more curvature
Years to maturity
6.54 y
YTM source
Ingested
Fund disclosure
Market signals · funds disclosing this bond
SignalCategoryExposureLast moveWeightAs of
iShares Convertible Bond
iShares
US Convertibles$12.8M▲ $46K0.21%2026-04-30
Subscribe to reveal which signals are holding this bond.Subscribe →

Price history

Sherpa Signal

AS OF 2026-04-30

Institutional footprint · signal-level holdings

18/ 100Minimal footprint
Interpretation. Minimal institutional footprint, holding
HOLDERS
1
unchanged in 7d
AGGREGATE EXPOSURE
$12.8M
USD across all
TOP CONCENTRATION
100.0%
largest holder
FLOW
▲ $109K
unchanged in 7d

Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.

100K PAR NOTIONAL · MARKET VALUE
98,988 USD
PRICE
98.99

RFQ routing · coming soon

Security details

VIA OPENFIGI
Canonical
HALO 0 7/8 11/15/32
FIGI
BBG01YCKR0K4
CUSIP
40637HAJ8
ISIN
US40637HAJ86
Type
Corp
Issued
2025-11-12
Face value
100 USD
Ticker
HALO 0.875 11/15/32
Sec. type
PRIV PLACEMENT
Seniority
Senior Unsecured

Issuer curve

HALO · 2 PTS

Yield (%) plotted against years-to-maturity. This bond highlighted in amber.